On the recordSeptember 25, 2019
H.R. 3 would ensure drug companies charge a fair price to patients while protecting access to lifesaving drugs and innovation.
Source
congress.govEditor's note · Context
Describes H.R. 3's goals to regulate drug pricing and maintain innovation.
Share
More from David Trone
Apr 9, 2024
I also want to reject a recent despicable effort, by some extreme far left groups, that falsely claim to speak for the Jewish community to undermine the longstanding bipartisan support for this critical programming.
Jun 21, 2023
There was a victory on that front, a bipartisan one, that is, you know, not really talked about that often, and that was the revision of NAFTA, the USMCA.
Jun 21, 2023
I have good news. It is already happening: more than 13 million jobs created over the last two and a half years.
Other voices in this conversation
